Diaceutics PLC (AIM:DXRX)
162.00
0.00 (0.00%)
Oct 10, 2025, 4:42 PM GMT+1
Diaceutics Revenue
Diaceutics had revenue of 14.56M GBP in the half year ending June 30, 2025, with 46.76% growth. This brings the company's revenue in the last twelve months to 34.40M, up 31.83% year-over-year. In the year 2024, Diaceutics had annual revenue of 32.16M with 35.69% growth.
Revenue (ttm)
34.40M
Revenue Growth
+31.83%
P/S Ratio
3.99
Revenue / Employee
161.51K
Employees
199
Market Cap
137.10M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 32.16M | 8.46M | 35.69% |
Dec 31, 2023 | 23.70M | 4.20M | 21.51% |
Dec 31, 2022 | 19.50M | 5.56M | 39.88% |
Dec 31, 2021 | 13.94M | 1.25M | 9.82% |
Dec 31, 2020 | 12.70M | -746.00K | -5.55% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |